Clinical trials
Hypotension trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 11 |
| Not yet recruiting | 4 |
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| General Hospital of Ningxia Medical University | 5 |
| Affiliated Hospital of Jiaxing University | 2 |
| First Affiliated Hospital of Wannan Medical College | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| Peking Union Medical College Hospital | 2 |
| Ailin Luo | 1 |
| Air Force Military Medical University, China | 1 |
| Dalian Municipal Central Hospital | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
| Fudan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypotension | 33 |
| Hypertension | 3 |
| Postoperative Complications | 2 |
| Sepsis | 2 |
| Shock | 2 |
| Shock, Septic | 2 |
| Bradycardia | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
| Critical Illness | 1 |
| Hemophilia B | 1 |
Trials
Showing 76 to 33 of 33. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.